A Study to Evaluate the Effects of Two Different Meal Types, Omeprazole and Ranitidine on Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Subjects

Trial Profile

A Study to Evaluate the Effects of Two Different Meal Types, Omeprazole and Ranitidine on Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Omeprazole (Primary) ; Ranitidine (Primary) ; Danoprevir; Ritonavir
  • Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Hepatitis C; HIV infections; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 06 Jul 2012 Actual end date changed from Oct 2011 to Nov 2011 reported by ClinicalTrials.gov.
    • 16 Mar 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top